
Global Leukapheresis Devices Market Size & Share to 2027
Description
Global Leukapheresis Devices Market Size & Share to 2027
Global Leukapheresis Devices Market Size, Trends & Growth Opportunity, By Type (Apheresis Devices, Leukoreduction Filters, Leukopheresis Columns & Cell Separators, and Leukapheresis Disposables), By Application (Therapeutic Application and Research Application), By End User, By Region and Forecast till 2027
Global Leukapheresis Devices Market
Leukapheresis is a procedure which is used to treat lymphocytic leukemia patients with very high white blood cell (WBC) counts. Leukemia starts in early form of blood cells usually leucocytes (WBC) which helps to fight against infections caused by foreign particles. Leukapheresis devices are used during Leukapheresis procedures. These devices are classified into various types such as Apheresis Devices, Leukopheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables.
Market Drivers
Rise in incidences of leukemia and number of blood donations are considered as driving factors which are expected to boost the global leukopheresis devices market growth. For instance, as per the IARC (International Agency for Research on Cancer) in 2018, aproximately 437,033 leukemia cases were registed and 309,006 deaths are occurred because of leukemia, across the world. The need for blood and blood products is rising every year in various countries- especially in low and middle income countries. Transfusion of blood and their products help patients suffering from life threatening conditions to live longer and maintain quality of life and supports surgical and medical procedures. For instance, as per the information of American National Red Cross 2020, around 21 million blood components are transfused every year in United State. North America is expected to witness for largest share in leukapheresis devices market due to increase in prevalence and incidences of leukemia in North America. For instance, as per the Leukemia and Lymphoma Society and American cancer society, from year 2011 to 2015 in the United State leukemia was the sixth most common cause of death in both women and men.
Market Restraints
However, high cost of apheresis procedures and devices are major challenging factors which are expected to hinder the global leukapheresis devices market growth. For instance, in Unite State cost of apheresis procedure is around USD 2500 per treatment which is very high. Further, in India apheresis machine prices is approximately USD 23,459 and there is an apheresis kit which is required for separating components costing with approximate price USD 134. It is very costly for low-income people to afford.
Market Segmentation
Global Leukapheresis Devices Market is segmented into type such as Apheresis Devices, Leukoreduction Filters, Leukopheresis Columns & Cell Separators, and Leukapheresis Disposables, by application such as Therapeutic Application and Research Application. Further, market is segmented into end users such as Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnological Companies, and Blood Component Providers and Blood Centers.
Also, Global Leukapheresis Devices Market is segmented into is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as Asahi Kasei Medical Co. Ltd, Terumo BCT Inc, Haemonetics Corporation, Fresenius SE & Co. KGaA, STEMCELL Technologies Inc, Grifols, S.A, BioIVT,and Key Biologics, LLC.
Market Taxonomy
By Type
Global Leukapheresis Devices Market Size, Trends & Growth Opportunity, By Type (Apheresis Devices, Leukoreduction Filters, Leukopheresis Columns & Cell Separators, and Leukapheresis Disposables), By Application (Therapeutic Application and Research Application), By End User, By Region and Forecast till 2027
Global Leukapheresis Devices Market
Leukapheresis is a procedure which is used to treat lymphocytic leukemia patients with very high white blood cell (WBC) counts. Leukemia starts in early form of blood cells usually leucocytes (WBC) which helps to fight against infections caused by foreign particles. Leukapheresis devices are used during Leukapheresis procedures. These devices are classified into various types such as Apheresis Devices, Leukopheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables.
Market Drivers
Rise in incidences of leukemia and number of blood donations are considered as driving factors which are expected to boost the global leukopheresis devices market growth. For instance, as per the IARC (International Agency for Research on Cancer) in 2018, aproximately 437,033 leukemia cases were registed and 309,006 deaths are occurred because of leukemia, across the world. The need for blood and blood products is rising every year in various countries- especially in low and middle income countries. Transfusion of blood and their products help patients suffering from life threatening conditions to live longer and maintain quality of life and supports surgical and medical procedures. For instance, as per the information of American National Red Cross 2020, around 21 million blood components are transfused every year in United State. North America is expected to witness for largest share in leukapheresis devices market due to increase in prevalence and incidences of leukemia in North America. For instance, as per the Leukemia and Lymphoma Society and American cancer society, from year 2011 to 2015 in the United State leukemia was the sixth most common cause of death in both women and men.
Market Restraints
However, high cost of apheresis procedures and devices are major challenging factors which are expected to hinder the global leukapheresis devices market growth. For instance, in Unite State cost of apheresis procedure is around USD 2500 per treatment which is very high. Further, in India apheresis machine prices is approximately USD 23,459 and there is an apheresis kit which is required for separating components costing with approximate price USD 134. It is very costly for low-income people to afford.
Market Segmentation
Global Leukapheresis Devices Market is segmented into type such as Apheresis Devices, Leukoreduction Filters, Leukopheresis Columns & Cell Separators, and Leukapheresis Disposables, by application such as Therapeutic Application and Research Application. Further, market is segmented into end users such as Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnological Companies, and Blood Component Providers and Blood Centers.
Also, Global Leukapheresis Devices Market is segmented into is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as Asahi Kasei Medical Co. Ltd, Terumo BCT Inc, Haemonetics Corporation, Fresenius SE & Co. KGaA, STEMCELL Technologies Inc, Grifols, S.A, BioIVT,and Key Biologics, LLC.
Market Taxonomy
By Type
- Apheresis Devices
- Leukoreduction Filters
- Leukopheresis Columns & Cell Separators
- Leukapheresis Disposables
- Therapeutic Application
- Research Application
- Hospitals
- Academic and Research Institutes
- Pharmaceutical and Biotechnological Companies
- Blood Component Providers and Blood Centers
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- What are the Key Opportunities in Global Leukapheresis Devices Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Table of Contents
157 Pages
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market Definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Leukapheresis Devices Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Leukapheresis Devices Market, By Type
- 5.1 Y-o-Y Growth Comparison, By Type
- 5.2 Global Leukapheresis Devices Market Share Analysis, By Type
- 5.3 Global Leukapheresis Devices Market Size and Forecast, By Type
- 5.3.1 Apheresis Devices
- 5.3.2 Leukoreduction Filters
- 5.3.3 Leukopheresis Columns & Cell Separators
- 5.3.4 Leukapheresis Disposables
- 6 Global Leukapheresis Devices Market, By Application
- 6.1 Y-o-Y Growth Comparison, By Application
- 6.2 Global Leukapheresis Devices Market Share Analysis, By Application
- 6.3 Global Leukapheresis Devices Market Size and Forecast, By Application
- 6.3.1 Therapeutic Application
- 6.3.2 Research Application
- 7 Global Leukapheresis Devices Market, By End User
- 7.1 Y-o-Y Growth Comparison, By End User
- 7.2 Global Leukapheresis Devices Market Share Analysis, By End User
- 7.3 Global Leukapheresis Devices Market Size and Forecast, By End User
- 7.3.1. Hospital
- 7.3.2. Academic and Research Institutes
- 7.3.3. Pharmaceutical and Biotechnological Companies
- 7.3.4. Blood Component Providers and Blood Centers
- 8 Global Leukapheresis Devices Market, By Region
- 8.1 Global Leukapheresis Devices Market Share Analysis, By Region
- 8.2 Global Leukapheresis Devices Market Share Analysis, By Region
- 8.3 Global Leukapheresis Devices Market Size and Forecast, By Region
- 9 North America Leukapheresis Devices Market Analysis and Forecast (2020-2027)
- 9.1 Introduction
- 9.2 North America Leukapheresis Devices Market Share Analysis, By Type
- 9.3 North America Leukapheresis Devices Market Size and Forecast, By Application
- 9.4 North America Leukapheresis Devices Market Size and Forecast, By End User
- 9.5 North America Leukapheresis Devices Market Size and Forecast, By Country
- 9.5.1 U.S.
- 9.5.2 Canada
- 9.5.3 Mexico
- 10 EuropeLeukapheresis Devices Market Analysis and Forecast (2020-2027)
- 10.1 Introduction
- 10.2 Europe Leukapheresis Devices Market Share Analysis, By Type
- 10.3 Europe Leukapheresis Devices Market Size and Forecast, By Application
- 10.4 Europe Leukapheresis Devices Market Size and Forecast, By End User
- 10.5 Europe Leukapheresis Devices Market Size and Forecast, By Country
- 10.5.1 Germany
- 10.5.2 France
- 10.5.3 UK
- 10.5.4 Rest of Europe
- 11 Asia Pacific Leukapheresis Devices Market Analysis and Forecast (2020-2027)
- 11.1 Introduction
- 11.2 Asia Pacific Leukapheresis Devices Market Share Analysis, By Type
- 11.3 Asia Pacific Leukapheresis Devices Market Size and Forecast, By Application
- 11.4 Asia Pacific Leukapheresis Devices Market Size and Forecast, By End User
- 11.5 Asia Pacific Leukapheresis Devices Market Size and Forecast, By Country
- 11.5.1 China
- 11.5.2 Japan
- 11.5.3 India
- 11.5.4 Rest of Asia Pacific
- 12 Latin America Leukapheresis Devices Market Analysis and Forecast (2020-2027)
- 12.1 Introduction
- 12.2 Latin America Leukapheresis Devices Market Share Analysis, By Type
- 12.3 Latin America Leukapheresis Devices Market Size and Forecast, By Application
- 12.4 Latin America Leukapheresis Devices Market Size and Forecast, By End User
- 12.5 Latin America Leukapheresis Devices Market Size and Forecast, Country
- 13 Middle East Leukapheresis Devices Market Analysis and Forecast (2020-2027)
- 13.1 Introduction
- 13.2 Middle East Leukapheresis Devices Market Share Analysis, By Type
- 13.3 Middle East Leukapheresis Devices Market Size and Forecast, By Application
- 13.4 Middle East Leukapheresis Devices Market Size and Forecast, By End User
- 13.5 Middle East Leukapheresis Devices Market Size and Forecast, By Country
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Asahi Kasei Medical Co. Ltd
- 15.1.1 Overview
- 15.1.2 Offerings
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2. Terumo BCT Inc
- 15.2.1 Overview
- 15.2.2 Offerings
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3. Haemonetics Corporation
- 15.3.1 Overview
- 15.3.2 Offerings
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 Fresenius SE & Co. KGaA
- 15.4.1 Overview
- 15.4.2 Offerings
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 STEMCELL Technologies Inc
- 15.5.1 Overview
- 15.5.2 Offerings
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Grifols, S.A
- 15.6.1 Overview
- 15.6.2 Offerings
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 BioIVT
- 15.7.1 Overview
- 15.7.2 Offerings
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 Biologics, LLC
- 15.8.1 Overview
- 15.8.2 Offerings
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.